3861 results for «2503»

Filter By

3861 results

Complex mitral interventions

19 Nov 2023 – From PCR London Valves 2023

What are the one-year outcomes of transfemoral TMVR? How does TMVI compare with SMVR in elderly patients at intermediate risk? What is the value of mitral ViV and mitral valve-in-ring in high-surgical-risk patients? Find the answers here!

Complex mitral interventions

Advancing valve repair: mastering diverse mitral and tricuspid regurgitation anatomies with the PASCAL Precision system

20 Nov 2023 – From PCR London Valves 2023

Participate in this session to stay informed about the latest clinical and real-world evidence for mitral and tricuspid TEER using PASCAL. Explore case-based discussions on mitral regurgitation treatment using PASCAL Precision, and actively participate in an educational tricuspid TEER recorded case procedure featuring the PASCAL Precision.

Advancing valve repair: mastering diverse mitral and tricuspid regurgitation anatomies with the PASCAL Precision system

Defying complexity: achieving optimal TAVI procedural outcomes in challenging anatomies with the new Evolut FX

20 Nov 2023 – From PCR London Valves 2023

Watch this session to understand factors to consider when deciding on valve selection, recognize the significance of device choice and implantation technique in redo-TAVI, and acquire insights into anticipating challenges associated with implanting a bicuspid valve, large anatomy, and a horizontal aorta.

Defying complexity: achieving optimal TAVI procedural outcomes in challenging anatomies with the new Evolut FX

TAVI - computer simulation and pre-procedural modelling

19 Nov 2023 – From PCR London Valves 2023

TAVI unleashed: optimisation of immediate and long-term outcomes

20 Nov 2023 – From PCR London Valves 2023

Consult this session if you want to gain insights into the effects of paravalvular leak, conduction disturbances, stroke, and permanent pacemaker issues following transcatheter aortic valve implantation. The discussion also delves into the design of transcatheter heart valves and its implications for selecting the initial valve...

TAVI unleashed: optimisation of immediate and long-term outcomes

TAVI for aortic regurgitation

19 Nov 2023 – From PCR London Valves 2023

In the face of aortic regurgitation, learn about various TAVI rescue techniques in this session, including valve implantation in the descending aorta, TAVI treatment of aortic regurgitation with cardiogenic shock, and TAVI management of aortic regurgitation in a patient with a left ventricular assist device.

TAVI for aortic regurgitation

Tricuspid transcatheter valve replacement: Cardiovalve keeps things in motion

20 Nov 2023 – From PCR London Valves 2023

Participate in this session to stay informed about the latest advancements in TTVR, receive updates on the Cardiovalve tricuspid program, and gain insights into how imaging demonstrates the concept underlying Cardiovalve transcatheter valve replacement technology.

Tricuspid transcatheter valve replacement: Cardiovalve keeps things in motion

TAVI - Alternative access - Part 1

19 Nov 2023 – From PCR London Valves 2023

Learn more about the evolving landscape of TAVI techniques and access options with this session: experience the first-hand application of JenaValve Trilogy via transaxillary access in treating aortic regurgitation, delve into the challenges and solutions of transcaval TAVI in a patient with right iliac vein occlusion,...

TAVI - Alternative access - Part 1

Essentials of lifetime management of TAVI patients

21 Nov 2023 – From PCR London Valves 2023

Consult this session if you want to learn about the next generation transcatheter heart valve technology key features, procedural and clinical benefits, to learn tips and tricks for managing bicuspid and valve-in-valve interventions, and to understand procedural and clinical relevance of intermediate and XL sizes in...

Essentials of lifetime management of TAVI patients

VitaFlow - The electrically enable self-expanding TAVI valve

21 Nov 2023 – From PCR London Valves 2023

This session provides insights into the unique design and advantages of VitaFlow Liberty for TAVI. It covers techniques to minimize microdislodgement during the procedure, identifies situations and patient types most suitable for VitaFlow Liberty, and reviews early clinical results associated with this technology.

VitaFlow - The electrically enable self-expanding TAVI valve

TAVI: haemodynamic considerations

19 Nov 2023 – From PCR London Valves 2023

Consult this session to gain a comprehensive understanding of the hemodynamic considerations in TAVI: delve into the comparative analysis of invasive and echocardiographic assessments to discern transvalvular pressure gradients post-TAVI, witness the validation of non-invasive volume-pressure loop analysis as an effective tool for patients with aortic...

TAVI: haemodynamic considerations

Facing the challenges of resource shortages - An outlook into the future of TAVI?

21 Nov 2023 – From PCR London Valves 2023

Join this session to discover strategies for optimizing care quality and patient safety, especially in resource-constrained environments. Gain insights into variations in TAVI patient treatment across European countries, understanding the associated consequences. Engage in discussions exploring potential solutions to ensure long-term, high-quality patient care despite challenges...

Facing the challenges of resource shortages - An outlook into the future of TAVI?

Mitral TEER - Part 1

19 Nov 2023 – From PCR London Valves 2023

Consult this session to gain insights into the complexities of Mitral TEER: witness an innovative solution for recurrent mitral regurgitation post-M-TEER showcasing the efficacy of three MitraClips, navigate the challenging terrain of mitral flail repair in a patient with a left main chronic total occlusion, explore...

Mitral TEER - Part 1

An intrepid solution for transfemoral treatment of mitral regurgitation

21 Nov 2023 – From PCR London Valves 2023

In this session, get insights into the APOLLO EU trial and its current progress, obtain a comprehensive understanding of the latest data from the Early Feasibility TF trial, and discern which patients stand to benefit the most from this treatment.

An intrepid solution for transfemoral treatment of mitral regurgitation

Best contemporary clinical practice for TAVI

21 Nov 2023 – From PCR London Valves 2023

Watch this session if you wish to explore emerging trends for transcatheter aortic valve implantation in younger patients, the specific considerations for TAVI in individuals with an extended life expectancy, and examine how valve design and implantation techniques can impact long-term outcomes.

Best contemporary clinical practice for TAVI

Mitral Late-Breaking Trials: CLASP IID, AltaValve transseptal programme, MitraSwiss in men and women, MiCLASP...

19 Nov 2023 – From PCR London Valves 2023

Discover the mitral late-breaking trials which were presented during PCR London Valves 2023: 

  • One-year outcomes of transcatheter mitral repair from the CLASP IID Registry
  • AltaValve transseptal programme update
  • Mitral TEER in men and women from MitraSwiss registry: is equality achieved?
  • Combined impact of mitral valve gradients and mitral regurgitation reduction...
Mitral Late-Breaking Trials - PCR London Valves 2023

Tricuspid Late-Breaking Trials: TRISCEND at 2 years, TEER in primary tricuspid regurgitation, TriCLASP, bRIGHT...

19 Nov 2023 – From PCR London Valves 2023

Discover the tricuspid late-breaking trials which were presented during PCR London Valves 2023: 

  • TRISCEND study two-year outcomes: transfemoral TTVR
  • Transcatheter edge-to-edge repair in patients with primary tricuspid regurgitation
  • One-year outcomes of transcatheter tricuspid valve repair from the TriCLASP study
  • TTVR with the LuX-Valve system: one-year outcomes of a multicentre experience
  • Real-world...
Tricuspid Late-Breaking Trials

Late-breaking trials on latest-generation aortic valves and dedicated transcatheter devices

20 Nov 2023 – From PCR London Valves 2023

Find out the outcomes of the main studies on the latest-generation valves and devices presented at PCR LV 2023 to better determine their benefits, performance and interest in the treatment of specific aortic pathologies: REACCESS-2 Study, ACURATE Neo2 PMCF post-market registry, OCEAN-TAVI registry, ShortCut Pivotal Study, and...

Late-breaking trials on latest-generation aortic valves and dedicated transcatheter devices

The Top Late-Breaking Trials: TRISCEND II, TRILUMINATE at 3 years, EuroSMR score, CLASP IID, OPERA-TAVI...

19 Nov 2023 – From PCR London Valves 2023

Discover the top late-breaking trials which were presented during PCR London Valves 2023:

  • TRISCEND II: A randomised trial of transcatheter tricuspid valve replacement vs medical therapy
  • Percutaneous edge-to-edge repair for tricuspid regurgitation: TRILUMINATE trial three-year outcomes
  • Transcatheter mitral valve-in-valve vs. redo surgical replacement for degenerated bioprostheses
  • Artificial intelligence derived risk...
PCR London Valves 2023 Top Late-Breaking Trials

TAVI outcomes - Part 1

19 Nov 2023 – From PCR London Valves 2023

Learn more about TAVI outcomes with this session: examine the impact of high-gradient and discordant low-gradient aortic stenosis, discover the potential of patient-specific computer simulation, explore the critical factor of time to TAVI and its implications in decompensated aortic stenosis cases, dive into the POPular TAVI...

TAVI outcomes - Part 1
Didn’t find what you were looking for?